Safety and Efficacy Study of Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies

Study Summary

The primary purpose of this study is to determine the safety and efficacy of novel autologous CAR-T cells in patients with hematopoietic and lymphoid malignancies.

Interventions

Study Locations

Facility	City	State	Country
Shanghai Pudong Hospital, Fudan University Affiliated Pudong Medical Center	Shanghai	Shanghai Municipality	China

Official Trial Information

View on ClinicalTrials.gov